Smartleaf Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Smartleaf Asset Management's VRTX Position: Q2 2026 in Review
Smartleaf Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 4,540 shares worth $2.27M. The position accounts for 0.07% of the portfolio, ranked #235.
Smartleaf Asset Management first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Smartleaf Asset Management held 4,540 shares of Vertex Pharmaceuticals worth $2.27M as of Q2 2026.
- Smartleaf Asset Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
- Vertex Pharmaceuticals made up 0.07% of Smartleaf Asset Management's portfolio in Q2 2026, its #235 holding.
- Smartleaf Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.